Pharmaceutical and Biotechnology Research Boosts Demand for Digital PCR and Real-Time PCR Solutions

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is expanding as molecular diagnostics, genetic research, oncology testing, infectious disease detection, and biopharmaceutical development increasingly depend on accurate nucleic acid amplification and quantification technologies. According to Maximize Market Research, the market was valued at USD 7.22 billion in 2025 and is projected to reach nearly USD 15.68 billion by 2034, growing at a 9% CAGR from 2026 to 2034.

Digital PCR and real-time PCR technologies enable laboratories to detect and quantify DNA and RNA with high sensitivity and precision. Their applications extend across clinical diagnostics, oncology, forensics, pharmaceutical and biotechnology research, academic laboratories, and contract research organizations. Increasing demand for molecular testing, genetic analysis, and advanced diagnostic technologies is creating opportunities for instrument, reagent, software, and service providers.

The growing adoption of digital PCR is supported by improvements in sensitivity, precision, robustness, and quantitative analysis. Meanwhile, qPCR remains an important technology for routine molecular testing and research applications. Increasing investments in life sciences, the expansion of clinical laboratories, and advances in PCR-based workflows are expected to support continued market development.

* Make Smarter Business Decisions: https://www.maximizemarketresearch.com/request-sample/32992/ 

Market Growth Drivers

• Rising demand for molecular diagnostics: Growing use of PCR technologies in infectious disease testing, genetic testing, oncology, and clinical diagnostics is supporting market expansion.
• Increasing prevalence of genetic and infectious diseases: The need for accurate detection and monitoring is encouraging healthcare providers and laboratories to adopt advanced PCR platforms.
• Growth in oncology applications: PCR-based technologies are increasingly utilized for cancer-related molecular analysis, supporting demand for sensitive and quantitative testing solutions.
• Advancements in digital PCR: Improved sensitivity, precision, absolute quantification, and robustness are increasing interest in dPCR technologies.
• Expansion of pharmaceutical and biotechnology research: Drug discovery, gene therapy, cell therapy, and molecular research are creating additional demand for PCR instruments and reagents.
• Growing research and clinical outsourcing: Expansion of contract research organizations and outsourced laboratory services is increasing the utilization of molecular testing technologies.
• Increasing investment in life sciences: Government support, research funding, and development of advanced laboratory infrastructure are contributing to adoption across major markets.

Key Market Segments

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market can be segmented based on product, application, end user, and region. By product, the market includes instruments, reagents, software, and services. Instruments and reagents remain fundamental components of PCR workflows, while software and services are becoming increasingly important as laboratories seek integrated and efficient molecular testing solutions.

By application, the market covers clinical, oncology, and forensics. Clinical applications represent a major area of utilization as PCR technologies support molecular diagnostics and disease detection. Oncology applications are also gaining importance because of increasing demand for molecular characterization and cancer-related testing.

By end user, the market includes hospitals, diagnostic laboratories, academia, pharmaceutical and biotechnology companies, and contract research organizations (CROs). Diagnostic laboratories and pharma-biotech organizations represent important users of PCR technologies for routine testing, research, drug development, and advanced molecular analysis.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Key Players

Thermo Fisher Scientific Inc.

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

QIAGEN N.V.

Takara Bio Inc.

Agilent Technologies, Inc.

Standard BioTools

Danaher Corporation

Abbott Laboratories

Merck KGaA

Emerging Trends

• Growing adoption of digital PCR: Laboratories are increasingly exploring dPCR for high-sensitivity detection and absolute quantification.
• Expansion of multiplex PCR: Multiplexing capabilities are enabling laboratories to analyze multiple targets within a single workflow.
• Automation of molecular workflows: Automated sample handling and integrated systems are improving laboratory efficiency, reproducibility, and throughput.
• Growth of oncology diagnostics: PCR technologies are increasingly being incorporated into molecular cancer testing and research.
• Increasing use in gene and cell therapy: dPCR is gaining importance for precise quantification in advanced biopharmaceutical workflows.
• Integration of software and data analysis: Advanced software is supporting automated analysis, interpretation, and management of PCR-generated data.
• High-throughput laboratory testing: Clinical and research laboratories are seeking faster workflows and scalable platforms to accommodate increasing testing volumes.
• Development of advanced PCR assays: Manufacturers are focusing on highly sensitive, specific, multiplexed, and application-specific assays for clinical and research use.

Recent Developments

• Thermo Fisher Scientific: In February 2025, Thermo Fisher Scientific received U.S. FDA 510(k) clearance for its TaqPath Flu A, Flu B, COVID-19, and RSV Select Panel multiplex PCR assay, expanding its molecular diagnostic capabilities for respiratory pathogen testing.
• QIAGEN: In April 2025, QIAGEN launched target-specific QIAcuity Digital PCR Assay Kits designed for specialized cell and gene therapy workflows, supporting precise quantification in biopharmaceutical applications.
• Bio-Rad Laboratories: In June 2025, Bio-Rad completed its USD 257.7 million acquisition of Stilla Technologies, adding the Naica digital PCR platform to its portfolio and strengthening its digital PCR capabilities.
• Bio-Rad Laboratories: In July 2025, Bio-Rad commercially launched four new Droplet Digital PCR platforms, including the QX Continuum and QX700 Series systems, expanding its multiplexing and molecular testing capabilities.
• QIAGEN and Hamilton: In January 2026, QIAGEN partnered with Hamilton to introduce automated nanoplate handling integration for QIAcuity dPCR systems, targeting higher-throughput and more reproducible laboratory workflows.
• Thermo Fisher Scientific: In January 2026, Thermo Fisher launched the TaqMan Cells-to-CT HepatoExpress Kit for direct gene-expression qPCR profiling without RNA extraction, supporting faster preclinical research workflows.

Regional Outlook

North America held the highest share of the global Digital PCR and Real-Time PCR market in 2025 and is projected to remain a leading regional market. The region benefits from advanced healthcare and research infrastructure, significant funding for qPCR and dPCR technologies, established diagnostic industries, the presence of major market participants, and growing demand for molecular testing.

Europe represents another important market, supported by established healthcare systems, pharmaceutical and biotechnology research, clinical laboratories, and growing applications of molecular diagnostics and genetic testing.

Asia-Pacific is projected to register the fastest CAGR during the forecast period. Growth is supported by emerging healthcare markets, an aging population, increasing incidence of genetic diseases, government support for life-science research, expanding clinical research outsourcing, and the growing number of CROs. China, India, Japan, South Korea, and other regional markets are creating opportunities for PCR technology providers.

Latin America is developing as PCR-based molecular diagnostics become more accessible and healthcare and laboratory infrastructure continues to expand.

Middle East & Africa are also creating opportunities through increasing healthcare investment, development of diagnostic capabilities, and growing adoption of advanced laboratory technologies.

Related Reports

Global Government Biometrics Market https://www.maximizemarketresearch.com/market-report/global-government-biometrics-market/34653/ 

Peptide and Oligonucleotide CDMO Market https://www.maximizemarketresearch.com/market-report/peptide-and-oligonucleotide-cdmo-market/188510/ 

Global Ultracapacitors Market https://www.maximizemarketresearch.com/market-report/global-ultracapacitors-market/29819/ 

Conclusion

The Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is advancing as healthcare, pharmaceutical, biotechnology, and research organizations increasingly demand sensitive, precise, and efficient molecular analysis. The market is projected to grow from USD 7.22 billion in 2025 to nearly USD 15.68 billion by 2034, at a 9% CAGR during 2026–2034.

Continued demand for molecular diagnostics, oncology testing, genetic research, infectious disease detection, and biopharmaceutical development is expected to support market expansion. At the same time, innovations in digital PCR, multiplexing, automation, assay development, and high-throughput workflows are creating new opportunities for technology providers. The combination of expanding clinical applications and increasing life-science research investment is expected to remain a key factor shaping the global PCR market over the forecast period.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 [email protected]